VaramirStart free · no cardSign in
AXSM as of Oct 31 · 01:51 ET
AXSMNasdaqPharmaceutical Preparations

Axsome Therapeutics, Inc. · Brief

Next report

2 days

Nov 2 · before openconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±6.8%
avg realized
±3.9%
Feb 18 '25±5.9%▼−2.33%×0.40
May 5 '25±7.1%▲+3.81%×0.53
Aug 4 '25±7.6%▲+3.42%×0.45
Q3 FY25±7.4%▲+0.56%×0.08
Jan 12 '26±3.7%▲+4.39%×1.19
Feb 23 '26±7.1%▼−4.88%×0.68
Q1 FY26±6.3%▲+8.31%×1.31
Q2 FY26±9.0%▲+3.83%×0.43
quarterimplied−10%0+10%realized×
Q2 FY26±9.0%▲+3.83%×0.43
Q1 FY26±6.3%▲+8.31%×1.31
Feb '26±7.1%▼−4.88%×0.68
Jan '26±3.7%▲+4.39%×1.19
Q3 FY25±7.4%▲+0.56%×0.08
Aug '25±7.6%▲+3.42%×0.45
2 older reports
May '25±7.1%▲+3.81%×0.53
Feb '25±5.9%▼−2.33%×0.40
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · confirmed

Bull2

12disclosed supplier and customer ties in SEC filingsSEC filings
508managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

13 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
−2.44%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

AXSM report session

Suppliers 1

JAZZJazz×0.23
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±10.9% into Nov 2 earnings (Oct 19 close).Source
Oct 7report dateEarnings date confirmed: Nov 2, before open.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.